The Effects of Maternal Magnesium Sulfate Treatment on Newborns: A Prospective Controlled Study

Journal of Perinatology

Volumn 18, Issue 6 SUPPL. 1, 1998, Pages 449-454

  Riaz, Mohammad ^a   Porat, Rachel ^a,b   Brodsky, Nancy L ^a,b   Hurt, Hallam ^a,b  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE; UTERUS SPASMOLYTIC AGENT;

APGAR SCORE; ARTICLE; CASE CONTROL STUDY; ECLAMPSIA; FEMALE; HUMAN; MUSCLE HYPOTONIA; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PROSPECTIVE STUDY; STATISTICAL ANALYSIS;

APGAR SCORE; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; ECLAMPSIA; FEMALE; HUMANS; MAGNESIUM SULFATE; MUSCLE HYPOTONIA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; TOCOLYTIC AGENTS;

EID: 0032199014     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Pricchard JA, Pritchard SA. Standardized treatment of 154 consecutive cases of eclampsia. AmJ Obstet Gynecol 1975;123:543-52.
2. Sibai BM. Eclampsia VI: maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990;163:1049-55.
3. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333:201-5.
4. Hollander HI, Nagey DA, Pupkin MJ. Magnesium sulfate and ritodrine hydrochloride: a randomized comparison. Am J Obstet Gynecol 1987; 156:631-7.
5. Cox SM, Sherman ML, Leveno KJ. Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol 1990;163:767-72.
6. Daftary AR, Rauk PN, Caritis SN. A pharmacokinetic approach to preterm labor inhibition. J Matern Fetal Med 1992;1:104-16.
7. Mudge GH. Magnesium. In: Goodman LS, Gilman A, editors. The Pharmacological Basis of Therapeutics. 6th ed. Chapter 35. New York: Macmillan; 1980. p. 879-82.
8. Roberts JM. Pregnancy related hypertension. Maternal-Fetal Medicine: Principles and Practice. 3rd ed. Philadelphia: W. B. Saunders; 1989. p. 829-31.
9. Rasch DK, Huber PA, Richardson CJ, L'Hommedieu CS, Nelson TE, Reddi R. Neurobehavioral effects or neonatal hypermagnesemia. J Pediatr 1982;100:272-6.
10. Cruikshank DP, Pitkin RM, Reynolds WA, William GA, Hargis GK. Effects of magnesium sulfate treatment on perinatal calcium metabolism: I. Maternal and fetal responses. Am J Obscet Gynecol 1979;134:243-9.
11. Stone SR, Pritchard JA. Effects of maternally administered magnesium sulfate on the neonate. Obstet Gynecol 1970;35:574-7.
12. Green WK, Key TC, Coen R, Resnik R. The effects of maternally administered magnesium sulfate on the neonate. Am J Obstet Gynecol 1983;146:29-33.
13. Lipsitz PJ, English IC. Hypermagnesemia in the newborn infant. Pediatr 1967;40:856-62.
14. Lipsitz PJ. The clinical and biochemical effects of excess magnesium in the newborn. Pediatr 1971;47:501-9.
15. Brazy JE, Grimm JK, Little VA. Neonatal manifestation of severe maternal hypertension occurring before the thirty-sixth week of pregnancy. J Pediatr 1982;100:265-71.
16. Riaz M, Brodsky NL, Porat R. Effects of maternal magnesium sulfate therapy on neonatal outcome [Abstract]. Pediatr Res 1995;37:1386.
17. Saunders N, Hammersley B. Magnesium for eclampsia. Lancet 1995;34: 788-9.
18. Sokal MM, Koenigsberger RM, Rose JS, Berdon WE, Santulli TV. Neonatal hypermagnesemia and the meconium plug syndrome. N Engl J Med 1972;286:823-5.
19. 4 therapy in preeclampsia-eclampsia. Obstet Gynecol 1981; 57:199-202